PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AbbVie Inc. (ABBV)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS00287Y1091
CUSIP00287Y109
SectorHealthcare
IndustryDrug Manufacturers - General

Highlights

Market Cap$304.29B
EPS (TTM)$3.36
PE Ratio51.29
PEG Ratio0.45
Total Revenue (TTM)$40.54B
Gross Profit (TTM)$27.59B
EBITDA (TTM)$11.69B
Year Range$132.11 - $179.55
Target Price$184.72
Short %0.92%
Short Ratio2.53

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


AbbVie Inc.

Popular comparisons: ABBV vs. ABT, ABBV vs. JNJ, ABBV vs. PFE, ABBV vs. MSFT, ABBV vs. VOO, ABBV vs. PEP, ABBV vs. SCHD, ABBV vs. EPD, ABBV vs. WMT, ABBV vs. ADI

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in AbbVie Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


200.00%300.00%400.00%500.00%600.00%700.00%FebruaryMarchAprilMayJuneJuly
693.12%
288.07%
ABBV (AbbVie Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

AbbVie Inc. had a return of 14.35% year-to-date (YTD) and 25.87% in the last 12 months. Over the past 10 years, AbbVie Inc. had an annualized return of 17.07%, outperforming the S&P 500 benchmark which had an annualized return of 10.77%.


PeriodReturnBenchmark
Year-To-Date14.35%15.41%
1 month1.48%0.33%
6 months6.53%13.74%
1 year25.87%21.39%
5 years (annualized)25.73%13.11%
10 years (annualized)17.07%10.77%

Monthly Returns

The table below presents the monthly returns of ABBV, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20247.10%7.09%3.44%-9.85%-0.86%6.38%14.35%
2023-7.71%4.16%3.55%-4.30%-8.71%-2.34%12.25%-1.75%1.43%-4.34%0.86%8.83%-0.23%
20222.15%7.95%9.70%-8.62%0.33%3.93%-5.42%-6.31%-0.19%10.19%10.10%0.27%24.01%
2021-3.24%5.13%0.45%4.28%1.52%-0.49%4.40%3.85%-10.69%7.59%0.53%17.45%32.43%
2020-7.26%5.79%-11.11%9.50%12.74%5.95%-2.15%0.91%-8.54%-1.52%22.89%2.46%27.72%
2019-11.84%-1.31%1.70%-0.18%-3.38%-5.20%-6.99%-1.32%15.18%6.59%10.28%0.92%1.47%
201816.87%3.22%-18.29%3.06%2.48%-6.36%0.56%4.07%-1.46%-16.81%21.09%-2.21%-0.96%
2017-1.43%1.19%5.37%2.20%0.12%9.83%-2.72%7.71%18.01%2.27%7.39%-0.22%60.07%
2016-6.35%-0.53%4.60%7.82%3.16%-1.62%7.92%-3.22%-1.61%-10.74%9.00%2.99%9.79%
2015-7.09%0.25%-3.24%11.37%2.98%0.90%4.97%-10.86%-12.82%10.46%-2.35%1.87%-6.50%
2014-6.04%3.41%0.96%2.23%4.32%3.88%-6.56%5.62%4.49%10.69%9.05%-5.43%27.92%
20138.69%0.63%10.46%13.97%-7.30%-3.16%11.03%-6.31%4.98%9.29%0.00%9.00%60.77%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current risk-adjusted rank of ABBV is 85, placing it in the top 15% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of ABBV is 8585
ABBV (AbbVie Inc.)
The Sharpe Ratio Rank of ABBV is 8787Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 8282Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 8383Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 9191Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 8383Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for AbbVie Inc. (ABBV) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ABBV
Sharpe ratio
The chart of Sharpe ratio for ABBV, currently valued at 1.59, compared to the broader market-2.00-1.000.001.002.003.001.59
Sortino ratio
The chart of Sortino ratio for ABBV, currently valued at 2.15, compared to the broader market-4.00-2.000.002.004.002.15
Omega ratio
The chart of Omega ratio for ABBV, currently valued at 1.30, compared to the broader market0.501.001.502.001.30
Calmar ratio
The chart of Calmar ratio for ABBV, currently valued at 1.89, compared to the broader market0.001.002.003.004.005.006.001.89
Martin ratio
The chart of Martin ratio for ABBV, currently valued at 5.32, compared to the broader market-30.00-20.00-10.000.0010.0020.005.32
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.82, compared to the broader market-2.00-1.000.001.002.003.001.82
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.59, compared to the broader market-4.00-2.000.002.004.002.59
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.32, compared to the broader market0.501.001.502.001.32
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.45, compared to the broader market0.001.002.003.004.005.006.001.45
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 6.82, compared to the broader market-30.00-20.00-10.000.0010.0020.006.82

Sharpe Ratio

The current AbbVie Inc. Sharpe ratio is 1.59. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of AbbVie Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.00FebruaryMarchAprilMayJuneJuly
1.59
1.82
ABBV (AbbVie Inc.)
Benchmark (^GSPC)

Dividends

Dividend History

AbbVie Inc. granted a 3.56% dividend yield in the last twelve months. The annual payout for that period amounted to $6.13 per share.


PeriodTTM20232022202120202019201820172016201520142013
Dividend$6.13$5.92$5.64$5.20$4.72$4.28$3.59$2.56$2.28$2.02$1.66$1.60

Dividend yield

3.56%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%3.03%

Monthly Dividends

The table displays the monthly dividend distributions for AbbVie Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$1.55$0.00$0.00$1.55$0.00$0.00$1.55$4.65
2023$1.48$0.00$0.00$1.48$0.00$0.00$1.48$0.00$0.00$1.48$0.00$0.00$5.92
2022$1.41$0.00$0.00$1.41$0.00$0.00$1.41$0.00$0.00$1.41$0.00$0.00$5.64
2021$1.30$0.00$0.00$1.30$0.00$0.00$1.30$0.00$0.00$1.30$0.00$0.00$5.20
2020$1.18$0.00$0.00$1.18$0.00$0.00$1.18$0.00$0.00$1.18$0.00$0.00$4.72
2019$1.07$0.00$0.00$1.07$0.00$0.00$1.07$0.00$0.00$1.07$0.00$0.00$4.28
2018$0.71$0.00$0.00$0.96$0.00$0.00$0.96$0.00$0.00$0.96$0.00$0.00$3.59
2017$0.64$0.00$0.00$0.64$0.00$0.00$0.64$0.00$0.00$0.64$0.00$0.00$2.56
2016$0.57$0.00$0.00$0.57$0.00$0.00$0.57$0.00$0.00$0.57$0.00$0.00$2.28
2015$0.49$0.00$0.00$0.51$0.00$0.00$0.51$0.00$0.00$0.51$0.00$0.00$2.02
2014$0.40$0.00$0.00$0.42$0.00$0.00$0.42$0.00$0.00$0.42$0.00$0.00$1.66
2013$0.40$0.00$0.00$0.40$0.00$0.00$0.40$0.00$0.00$0.40$0.00$0.00$1.60

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%3.6%
AbbVie Inc. has a dividend yield of 3.56%, which is quite average when compared to the overall market.
Payout Ratio
20.0%40.0%60.0%80.0%100.0%120.0%55.9%
AbbVie Inc. has a payout ratio of 55.93%, which is quite average when compared to the overall market. This suggests that AbbVie Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-15.00%-10.00%-5.00%0.00%FebruaryMarchAprilMayJuneJuly
-3.61%
-2.86%
ABBV (AbbVie Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the AbbVie Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the AbbVie Inc. was 45.09%, occurring on Aug 15, 2019. Recovery took 330 trading sessions.

The current AbbVie Inc. drawdown is 3.61%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-45.09%Jan 29, 2018390Aug 15, 2019330Dec 4, 2020720
-31.61%Jul 29, 201561Oct 22, 2015383May 2, 2017444
-21.92%Apr 11, 2022120Sep 30, 2022320Jan 10, 2024440
-19.82%Dec 8, 201443Feb 9, 201590Jun 18, 2015133
-14.2%Apr 1, 202442May 29, 2024

Volatility

Volatility Chart

The current AbbVie Inc. volatility is 6.71%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%8.00%FebruaryMarchAprilMayJuneJuly
6.71%
2.76%
ABBV (AbbVie Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of AbbVie Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

P/E Ratio

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for AbbVie Inc..


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items